back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-04-02 09:56 Tx date 2024-04-01 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,373
+158 vol $8.69 each |
10,315 | |
| Filed 2024-04-02 09:55 Tx date 2024-04-01 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+317 vol |
10,157 | |
| Filed 2024-03-30 09:00 Tx date 2024-03-27 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+1,293 vol |
9,840 | |
| Filed 2024-03-24 10:00 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$770.28
+98 vol $7.86 each |
7,680 | |
| Filed 2024-03-24 09:59 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,616
+211 vol $7.66 each |
7,582 | |
| Filed 2024-01-03 11:28 Tx date 2003-10-30 |
$RX
Hedley Technologies Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$25,000
+100,000 vol $0.25 each |
||
| Filed 2024-01-03 11:25 Tx date 2024-01-02 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$2,586
+289 vol $8.95 each |
8,238 | |
| Filed 2024-01-03 11:24 Tx date 2024-01-02 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$2,506
+280 vol $8.95 each |
||
| Filed 2024-01-03 11:23 Tx date 2024-01-02 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+578 vol |
7,949 | |
| Filed 2004-04-20 10:21 Tx date 2003-10-30 |
$RX
Hedley Technologies Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$25,000
+100,000 vol $0.25 each |
||
| Filed 2004-04-14 14:23 Tx date 2003-10-30 |
$RX
Hedley Technologies Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
+100,000 vol |
||
| Filed 2023-10-04 09:14 Tx date 2023-10-02 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$2,255
+287 vol $7.86 each |
107,371 | |
| Filed 2023-07-04 09:01 Tx date 2023-06-30 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$2,142
+286 vol $7.49 each |
107,084 | |
| Filed 2023-07-04 09:00 Tx date 2023-06-30 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+573 vol |
106,798 | |
| Filed 2023-04-03 09:09 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+1,409 vol |
106,225 | |
| Filed 2023-03-15 09:56 Tx date 2022-12-31 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$204.45
+29 vol $7.05 each |
104,816 | |
| Filed 2023-03-15 09:54 Tx date 2022-12-31 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,275
+152 vol $8.39 each |
104,787 | |
| Filed 2022-04-01 09:10 Tx date 2022-03-31 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+1,072 vol |
104,635 | |
| Filed 2022-03-22 08:21 Tx date 2021-12-31 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$671.44
+88 vol $7.63 each |
103,563 | |
| Filed 2021-03-23 13:51 Tx date 2021-03-19 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+1,224 vol |
103,475 | |
| Filed 2020-04-01 09:49 Tx date 2020-03-31 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+2,251 vol |
102,251 | |
| Filed 2018-06-01 Tx date 2018-01-08 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$10,905
+1,136 vol $9.60 each |
1,136 | |
| Filed 2018-06-01 Tx date 2018-05-29 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$31,012
+3,120 vol $9.94 each |
4,256 | |
| Filed 2018-06-01 Tx date 2003-10-21 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares - Options
00 - Opening Balance-Initial SEDI Report
|